Clinical Trial Update: Reboxetine for Sleep Apnoea After ENT Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating reboxetine for obstructive sleep apnea after ENT surgery is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Reboxetine (Reboxetine)

Snippet

Sponsor: Flinders University | Conditions: Sleep Apnea, Obstructive | Phase 2 | Status: RECRUITING